Search results for "Amlexanox"

showing 3 items of 3 documents

Translational readthrough of ciliopathy genes BBS2 and ALMS1 restores protein, ciliogenesis and function in patient fibroblasts

2021

Abstract Background Ciliary dysfunction underlies a range of genetic disorders collectively termed ciliopathies, for which there are no treatments available. Bardet-Biedl syndrome (BBS) is characterised by multisystemic involvement, including rod-cone dystrophy and renal abnormalities. Together with Alstrom syndrome (AS), they are known as the ‘obesity ciliopathies’ due to their common phenotype. Nonsense mutations are responsible for approximately 11% and 40% of BBS and AS cases, respectively. Translational readthrough inducing drugs (TRIDs) can restore full-length protein bypassing in-frame premature termination codons, and are a potential therapeutic approach for nonsense-mediated ciliop…

BBS2AdultMaleMedicine (General)AdolescentNonsense mutationAminopyridinesCell Cycle ProteinsCiliopathiesGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundR5-920AtalurenCiliogenesismedicineHumansReceptors SomatostatinBardet-Biedl SyndromeAlstrom SyndromeCells CulturedOxadiazolesbusiness.industryTumor Suppressor ProteinsTranslational readthroughRProteinsGeneral MedicineFibroblastsmedicine.diseaseNonsense suppressionCiliopathiesAtalurenCiliopathyALMS1chemistryCodon NonsenseAmlexanoxCancer researchMedicineBBS2businessAlström syndromeResearch PaperEBioMedicine
researchProduct

Treatment of recurrent aphthous stomatitis. A literature review

2014

Recurrent aphthous stomatitis (RAS) is the most common chronic disease of the oral cavity, affecting 5-25% of the population. The underlying etiology remains unclear, and no curative treatment is available. The present review examines the existing treatments for RAS with the purpose of answering a number of questions: How should these patients be treated in the dental clinic? What topical drugs are available and when should they be used? What systemic drugs are available and when should they be used? A literature search was made of the PubMed, Cochrane and Scopus databases, limited to articles published between 2008-2012, with scientific levels of evidence 1 and 2 (metaanalyses, systematic …

medicine.medical_specialtyPathologyTriamcinolone acetonidePopulationOdontologíaReviewRecurrent aphthous stomatitislaw.inventionRandomized controlled trialPrednisonelawmedicineeducationGeneral Dentistryeducation.field_of_studyOral Medicine and Pathologybusiness.industry:CIENCIAS MÉDICAS [UNESCO]DermatologyCiencias de la saludThalidomideSystematic reviewAmlexanoxUNESCO::CIENCIAS MÉDICASbusinessmedicine.drug
researchProduct

Effectiveness of amlexanox and adcortyl for the treatment of recurrent aphthous ulcers

2015

Background Recurrent aphthous stomatitis (RAS) is a common condition that affects approximately 20% of the general population. The ulcers can interfere with speech and eating and cause significant pain and discomfort. This study aimed to evaluate the efficacy of Amlexanox and Adcortyl in the treatment of aphthous ulcers. Material and Methods In this randomized double blind clinical trial with sequential patient entry, a total of 40 patients who presented with aphthous ulcers were included. Patients were received Amlexanox or Adcortyl four times daily for 7 days. Patients were evaluated for pain, lesion size, and tingling at one day, three days, five days and seven days follow-ups. The treat…

medicine.medical_specialtyPopulationOdontologíaRecurrent aphthous stomatitisDouble blindLesion03 medical and health sciences0302 clinical medicinemedicineeducationGeneral DentistryPain scoreeducation.field_of_studyOral Medicine and Pathologybusiness.industryResearch030206 dentistryCiencias de la saludDermatologySurgeryClinical trialAmlexanox030220 oncology & carcinogenesisUNESCO::CIENCIAS MÃ DICASTingling:CIENCIAS MÃ DICAS [UNESCO]medicine.symptombusinessmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct